On July 23, PCAC will discuss: BPC-157 KPV TB-500 MOTS-c On July 24, PCAC will discuss: Emideltide, also referred to as DSIP Semax Epitalon FDAs agenda identifies the following uses for its review: These are the uses FDA selected for this regulatory review
The standard protocol uses 2 to 3 mg GHK-Cu subcutaneously, five days per week, for 8 to 12 weeks
Unlike larger proteins, peptides are small enough to easily interact with cell receptors, triggering specific healing processes
Additionally, specific brainstem activations have been recorded 24 h before the headache begins (22, 23)
Possible side effects include mild irritation at the injection site, headaches, nausea, and others, depending on the specific peptide